Mengxin Lü

2.0k total citations
44 papers, 760 citations indexed

About

Mengxin Lü is a scholar working on Molecular Biology, Surgery and Plant Science. According to data from OpenAlex, Mengxin Lü has authored 44 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Plant Science. Recurrent topics in Mengxin Lü's work include Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (4 papers) and COVID-19 Clinical Research Studies (4 papers). Mengxin Lü is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (4 papers) and COVID-19 Clinical Research Studies (4 papers). Mengxin Lü collaborates with scholars based in China, United States and Germany. Mengxin Lü's co-authors include Xinghuan Wang, Yu Xiao, Gang Wang, Lingao Ju, Xuefeng Liu, Yongwen Luo, Song Chen, Qiangqiang Ge, Xiaolong Wang and Chin‐Lee Wu and has published in prestigious journals such as Oncogene, International Journal of Molecular Sciences and Cerebral Cortex.

In The Last Decade

Mengxin Lü

40 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengxin Lü China 16 398 189 150 99 98 44 760
Ping Ren China 15 281 0.7× 84 0.4× 225 1.5× 80 0.8× 46 0.5× 40 780
Mo Yang China 14 281 0.7× 76 0.4× 65 0.4× 37 0.4× 67 0.7× 40 711
Zhiyu Zhang China 11 348 0.9× 153 0.8× 223 1.5× 26 0.3× 39 0.4× 41 680
Dumnoensun Pruksakorn Thailand 18 370 0.9× 194 1.0× 195 1.3× 45 0.5× 23 0.2× 84 944
Xuelian Chen China 16 296 0.7× 124 0.7× 95 0.6× 91 0.9× 20 0.2× 46 873
Yanan Cheng China 13 372 0.9× 205 1.1× 76 0.5× 80 0.8× 15 0.2× 34 690
Xiaoyu Ren China 16 384 1.0× 184 1.0× 40 0.3× 31 0.3× 48 0.5× 42 780
Mingming Yang China 17 438 1.1× 180 1.0× 91 0.6× 28 0.3× 29 0.3× 80 966

Countries citing papers authored by Mengxin Lü

Since Specialization
Citations

This map shows the geographic impact of Mengxin Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxin Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxin Lü more than expected).

Fields of papers citing papers by Mengxin Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxin Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxin Lü. The network helps show where Mengxin Lü may publish in the future.

Co-authorship network of co-authors of Mengxin Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Mengxin Lü. A scholar is included among the top collaborators of Mengxin Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengxin Lü. Mengxin Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Liang, Gang Wang, Kaiyu Qian, et al.. (2025). RBPMS inhibits bladder cancer metastasis by downregulating MYC pathway through alternative splicing of ANKRD10. Communications Biology. 8(1). 367–367. 1 indexed citations
2.
Xu, Song, Hongjie Shi, Yu Fang, et al.. (2025). Outcomes of Second Resection Following Conventional Initial Transurethral Resection of Bladder Tumors. International Journal of Urology. 32(6). 720–726.
3.
Zhang, Xueyun, Chong Chen, Mengxin Lü, et al.. (2025). Long-term effects of peginterferon-based therapy versus nucleos(t)ide analogue monotherapy in non-cirrhotic HBeAg-positive chronic hepatitis B patients. Antiviral Research. 240. 106192–106192. 1 indexed citations
4.
Lü, Mengxin, Xinyan Li, Cong Du, et al.. (2024). Integrated analyses and a novel nomogram for the prediction of significant fibrosis in patients. Annals of Hepatology. 30(1). 101744–101744. 1 indexed citations
5.
Zhou, Fenfang, Zhao Deng, Mengxin Lü, et al.. (2024). DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11. Oncogene. 43(8). 594–607. 11 indexed citations
6.
7.
Zhang, Xiaoshan, Yue Xiao, Teng Wang, et al.. (2023). Kill two birds with one stone: Contribution of steel slag on enhancing the performance of coal gangue-based cementitious materials and simultaneous sulfur fixation. Journal of environmental chemical engineering. 11(6). 111169–111169. 8 indexed citations
8.
Wang, Danwen, Zhao Deng, Mengxin Lü, et al.. (2023). Integrated analysis of the roles of oxidative stress related genes and prognostic value in clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 149(13). 11057–11071. 7 indexed citations
9.
Chen, Song, Yejinpeng Wang, Yaoyi Xiong, et al.. (2021). Wild-type IDH1 inhibits the tumor growth through degrading HIF-α in renal cell carcinoma. International Journal of Biological Sciences. 17(5). 1250–1262. 11 indexed citations
10.
He, Zhiwen, Siming Chen, Mengxin Lü, et al.. (2021). A combination of laparoscopic approach and ERAS pathway optimizes outcomes and cost for adrenalectomy. Updates in Surgery. 74(2). 519–525. 5 indexed citations
11.
Lü, Mengxin, Xiaoxu Guan, Ming Wang, et al.. (2021). Clinical analysis and a novel risk predictive nomogram for 155 adult patients with hemophagocytic lymphohistiocytosis. Annals of Hematology. 100(9). 2181–2193. 11 indexed citations
12.
Chen, Chang, Yi Zhang, Jianying Huang, et al.. (2021). Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial. Frontiers in Pharmacology. 12. 683296–683296. 84 indexed citations
13.
Zhou, Fuling, Jingfeng Li, Mengxin Lü, et al.. (2020). Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey. EClinicalMedicine. 26. 100510–100510. 14 indexed citations
14.
Lü, Mengxin, et al.. (2020). Cloning of a SEPALLATA4-like gene (IiSEP4) in Isatis indigotica Fortune and characterization of its function in Arabidopsis thaliana. Plant Physiology and Biochemistry. 154. 229–237. 17 indexed citations
15.
Tang, Jianing, Jiangbo Ren, Qiuxia Cui, et al.. (2019). A prognostic 10‐lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients. Journal of Cellular and Molecular Medicine. 23(10). 6775–6784. 16 indexed citations
16.
Tang, Jianing, Mengxin Lü, Qiuxia Cui, et al.. (2019). Overexpression of ASPM, CDC20, and TTK Confer a Poorer Prognosis in Breast Cancer Identified by Gene Co-expression Network Analysis. Frontiers in Oncology. 9. 310–310. 60 indexed citations
17.
Li, Chao, et al.. (2019). Resveratrol induces apoptosis of benign prostatic hyperplasia epithelial cell line (BPH-1) through p38 MAPK-FOXO3a pathway. BMC Complementary and Alternative Medicine. 19(1). 233–233. 26 indexed citations
18.
Ma, Yanqin, et al.. (2019). Constitutive expression of NtabSPL6-1 in tobacco and Arabidopsis could change the structure of leaves and promote the development of trichomes. Journal of Plant Physiology. 240. 152991–152991. 2 indexed citations
19.
Lü, Mengxin, Qiangqiang Ge, Gang Wang, et al.. (2018). CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α. Cell Death and Disease. 9(10). 1046–1046. 44 indexed citations
20.
Fang, Jiacheng, Xiaoxiao Wang, Mengxin Lü, Xirui He, & Xinhua Yang. (2018). Recent advances in polysaccharides from Ophiopogon japonicus and Liriope spicata var. prolifera. International Journal of Biological Macromolecules. 114. 1257–1266. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ping Ren Breakdown of academic impact, for papers by Mo Yang Breakdown of academic impact, for papers by Zhiyu Zhang Breakdown of academic impact, for papers by Dumnoensun Pruksakorn Breakdown of academic impact, for papers by Xuelian Chen Breakdown of academic impact, for papers by Yanan Cheng Breakdown of academic impact, for papers by Xiaoyu Ren Breakdown of academic impact, for papers by Mingming Yang
Rankless by CCL
2026